B ALL
Clinical trials for B ALL explained in plain language.
Never miss a new study
Get alerted when new B ALL trials appear
Sign up with your email to follow new studies for B ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR-T showdown: new hope to stop Leukemia's return
Disease control Recruiting nowThis study compares two approaches for patients with B-cell acute lymphoblastic leukemia (B-ALL) who still show tiny amounts of cancer cells after a stem cell transplant. Researchers will test whether a personalized immune cell therapy (CAR-T) works better than standard chemother…
Matched conditions: B ALL
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New 'Living Drug' trial seeks to reboot immune system to fight childhood leukemia
Disease control Recruiting nowThis study is testing a new type of treatment called CD123-CAR T-cell therapy for children and young adults (up to age 21) whose blood cancers have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better target…
Matched conditions: B ALL
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'Living Drug' trial offers hope for kids and young adults battling leukemia that Won't quit
Disease control Recruiting nowThis study is testing a personalized cell therapy called Senl_B19 CAR-T for children and young adults (ages 3-25) whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, genetically modify…
Matched conditions: B ALL
Phase: PHASE2 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Double-Punch CAR-T trial offers hope for kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a new, experimental CAR-T cell therapy designed to fight two targets (CD19 and CD22) on cancer cells at once. It is for children and young adults (ages 3-39) whose B-cell leukemia or lymphoma has come back or hasn't responded to standard treatments. Doctors …
Matched conditions: B ALL
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New tests aim to predict leukemia relapse after groundbreaking CAR-T therapy
Disease control Recruiting nowThis study is testing whether a series of advanced blood and bone marrow tests can help doctors better monitor children and young adults with a type of leukemia (B-ALL) who have recently received CAR-T cell therapy. The goal is to see if these tests can identify who is at high ri…
Matched conditions: B ALL
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New cell therapy tested for leukemia patients out of options
Disease control Recruiting nowThis is the first human study to test the safety and early effects of an experimental cell therapy called KSV01. It's for adults aged 18-80 whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to standard treatments. The main goal is to find a safe dose by …
Matched conditions: B ALL
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Scientists test new Two-Pronged attack on tough blood cancers
Disease control Recruiting nowThis is a small, early-stage study for adults with B-cell leukemia or lymphoma that has come back or not responded to other treatments. The goal is to test the safety of a new two-step approach. First, patients receive a targeted radioactive drug (131-I apamistamab), followed by …
Matched conditions: B ALL
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Tracking the hidden toll: study follows kids after CAR-T cancer treatment
Knowledge-focused Recruiting nowThis study aims to learn about the long-term side effects of CAR-T cell therapy in children and young adults with cancer. Researchers will follow 100 participants for up to two years to track how often they get serious infections, have slow blood count recovery, or experience las…
Matched conditions: B ALL
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC